Abrdn Healthcare Investor... (HQH)
NYSE: HQH
· Real-Time Price · USD
19.05
0.15 (0.79%)
At close: Oct 15, 2025, 3:59 PM
19.06
0.05%
After-hours: Oct 15, 2025, 06:21 PM EDT
Abrdn Healthcare Investors Cash Flow Statement
Financials in USD. Fiscal
year is
October - September.
Fiscal Year | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
Period Ending | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Net Income | 85.25M | 99.7M | -26.83M | 83.16M | -79.18M | -115.05M | 66.61M | 88.57M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 43.01M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Accounts Receivables | 21.45K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Accounts Payables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 42.99M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Non-Cash Items | -119.54M | -99.7M | 26.83M | -83.16M | 79.18M | 115.05M | -66.61M | -88.57M |
Net Cash from Operating Activities | 8.72M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Cash Flow | 8.72M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PP&E Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Activities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Cash from Investing Activities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Debt Issuance | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Net Debt Issuance | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Net Debt Issuance | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Stock Issuance | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Common Stock Issuance | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Issuance | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Preferred Stock Issuance | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Dividends Paid | -16.78M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Dividends Paid | -16.78M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Preferred Dividends Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financing Activities | 8.06M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Cash from Financing Activities | -8.72M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Effect of Forex Changes on Cash | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Change in Cash | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash at End of Period | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash at Beginning of Period | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Free Cash Flow | 8.72M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Income Taxes Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Source: Financial Modeling Prep. Financial Sources.